Essai du traitement pré-clinique du carcinome hépatocellulaire sur la cirrhose dans le modèle de rat
Hepatocellular carcinoma (HCC) is the second most common cause of cancerrelated mortality worldwide. AKT pathway has been found activated in 50% of HCC cases, making it promising target. Therefore we assess efficacy of the allosteric AKT inhibitor or the combination of Sorafenib with AKT inhibitor c...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en |
| Published: |
2016
|
| Subjects: | |
| Online Access: | http://www.theses.fr/2016GREAV054/document |